GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Omega Alpha SPAC (NAS:OMEG) » Definitions » COGS-to-Revenue

Omega Alpha SPAC (Omega Alpha SPAC) COGS-to-Revenue : 0.00 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Omega Alpha SPAC COGS-to-Revenue?

Omega Alpha SPAC's Cost of Goods Sold for the three months ended in Sep. 2022 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2022 was $0.00 Mil.

Omega Alpha SPAC's COGS to Revenue for the three months ended in Sep. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Omega Alpha SPAC's Gross Margin % for the three months ended in Sep. 2022 was N/A%.


Omega Alpha SPAC COGS-to-Revenue Historical Data

The historical data trend for Omega Alpha SPAC's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omega Alpha SPAC COGS-to-Revenue Chart

Omega Alpha SPAC Annual Data
Trend Dec20 Dec21
COGS-to-Revenue
- -

Omega Alpha SPAC Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
COGS-to-Revenue Get a 7-Day Free Trial - - - - -

Omega Alpha SPAC COGS-to-Revenue Calculation

Omega Alpha SPAC's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Omega Alpha SPAC's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omega Alpha SPAC  (NAS:OMEG) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Omega Alpha SPAC's Gross Margin % for the three months ended in Sep. 2022 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Omega Alpha SPAC COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Omega Alpha SPAC's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Omega Alpha SPAC (Omega Alpha SPAC) Business Description

Traded in Other Exchanges
N/A
Address
888 Boylston Street, Suite 1111, Boston, MA, USA, 02199
Website
Omega Alpha SPAC is a blank check company.
Executives
Otello Stampacchia director, 10 percent owner, officer: Chief Executive Officer 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Alpha Management Omega 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02119
Joseph P Slattery director C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Martin Babler director C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Daniel Lynch director
Vincent Ossipow officer: Chief Scientific Officer CH. DES VIGNES 1, COMMUGNY V8 1291
Van De Winkel Jan director C/O HOOKIPA PHARMA INC., 430 EAST 29TH STREET 14TH FLOOR, NEW YORK NY 10016
Omega Fund Vi, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp Manager, Ltd. 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp, L.p. 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Michelle Doig director, officer: President C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Francesco Draetta officer: Chief Financial Officer C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Alexandra Pearsall 10 percent owner C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199

Omega Alpha SPAC (Omega Alpha SPAC) Headlines

From GuruFocus

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

By Business Wire Business Wire 01-07-2021

Omega Alpha Spac (OMEG) CEO Otello Stampacchia Bought $5 million of Shares

By GuruFocus Research GuruFocus Editor 01-14-2021